HER-2阳性的乳腺导管原位癌伴微浸润应如何治疗?
摘要
1982年,Lagios等首次提出了“微浸润乳腺癌”的概念,是指在病理上乳腺癌细胞突破基底膜进入邻近组织,其浸润最大直径不超过1mm^[1]。尽管这一概念已提出多年,但并未被广泛采用。关于“微浸润”还有很多定义,比如:伴间质浸润的导管原位癌(ductal carcinoma in situ,DCIS);
出处
《医学争鸣》
CAS
北大核心
2012年第2期38-39,共2页
Negative
参考文献5
-
1Lagios MD,Philip R,Westdahl MD,et al.Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures[].Cancer.1982
-
2Sobin LH,Wittekind C.TNM Classification of Malignant Tumours[]..1997
-
3Roses RE,Paulson EC,Shar ma A,et al.HER-2/neu overex-pression as a predictor for the transition fromin situto inva-sive breast cancer[].Cancer Epidemiology Biomarkers and Prevention.2009
-
4SY Wang,T Shamliyan,BA Virnig,R Kane.Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis[].Breast Cancer Research.2011
-
5Yang M,Moriya T,Oguma M,et al.Microinvasive ductal carcinoma (T1mic)of the breast.The clinicopathological profile and immunohistochemical features of28cases[].Pathology International.2003
-
1俸瑞发,宫晓洁.乳腺导管内癌的X线表现及临床价值[J].肿瘤防治杂志,2004,11(11):1181-1182. 被引量:2
-
2王鸿.乳腺导管内癌26例临床分析[J].中华肿瘤防治杂志,2007,14(16):1278-1278.
-
3连臻强,王颀.乳腺导管原位癌研究的进展[J].国际外科学杂志,2009,36(5):338-341. 被引量:3
-
4龙泉伊,李宏江.乳腺导管内癌的诊断与治疗[J].华西医学,2011,26(7):1000-1002. 被引量:6
-
5李萍,刘思良,王建红,禹静.超声对乳腺导管内癌的诊断价值[J].中国临床医学影像杂志,2009,20(11):857-858. 被引量:4
-
6刘大全,吴凯南.乳腺导管原位癌诊断和治疗的研究进展[J].肿瘤防治杂志,2002,9(3):347-349. 被引量:2
-
7李泉水,邓水平,张家庭,熊华花,陈胜华,童红玉.超声对乳腺导管原位癌的诊断价值[J].中国超声医学杂志,2010,26(10):896-898. 被引量:9
-
8Yun Niu,Yuxia Gao,Xue Yang,Yu Li,Yong Yu,Ajuan Lu.Expression of E2F-1, Rb and ER in Peripheral Papil-loma and Ductal Carcinoma in Situ of the Breast and its Significance[J].Chinese Journal of Clinical Oncology,2007,4(4):259-263.
-
9郭静,唐仁泉,张宇,张伟,于宵.CyclinE和p27在乳腺癌中的表达及临床意义[J].当代医学,2009,15(7):130-131. 被引量:7
-
10雷玉涛,赵红梅,侯宽永.乳腺导管原位癌临床诊治分析(附6例报告)[J].中国微创外科杂志,2005,5(10):871-872. 被引量:7